Inventor · disambiguated record
Xiaodong Xiao
Also filed as: XIAO XIAODONG
16 granted patents·11 pending applications·50 citations·filing 2006–2025
91Inventor score
Files withMEDIMMUNE LLC13BOSTON PHARMACEUTICALS INC4DIMITROV DIMITER S3HORIZON THERAPEUTICS IRELAND DAC2AMEMIYA KEI1
Top patents by PatentIndex Score
27 records- 0192US10988546B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2018·Granted Apr 27, 2021·8 cites·14 claims
- 0291US9598492B2Human monoclonal antibodies specific for CD22THE US SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2016·Granted Mar 21, 2017·8 cites·13 claims
- 0390US9279019B2Human monoclonal antibodies specific for CD22US HEALTH·Filed 2013·Granted Mar 8, 2016·10 cites·23 claims
- 0490US8591889B2Human monoclonal antibodies specific for CD22DIMITROV DIMITER S·Filed 2009·Granted Nov 26, 2013·12 cites·23 claims
- 0583US2025122276A1Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2024·Application pending·0 cites
- 0682US11117956B2Anti-O1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Sep 14, 2021·3 cites·25 claims
- 0780US11447542B2Anti-O2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Sep 20, 2022·1 cites·21 claims
- 0880US2024383969A1Anti-o1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0978US12209123B2Antibodies to Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 receptor ligand (FLT3L) and uses thereof for treating autoimmune and inflammatory diseasesHORIZON THERAPEUTICS IRELAND DAC·Filed 2022·Granted Jan 28, 2025·0 cites·19 claims
- 1076US10494435B2Human monoclonal antibodies specific for CD22THE GOVERNMENT OF THE U S A AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Dec 3, 2019·1 cites·14 claims
- 1176US8722046B2Human monoclonal antibodies protective against bubonic plagueAMEMIYA KEI·Filed 2010·Granted May 13, 2014·6 cites·16 claims
- 1276US2024294666A1BCMA Monoclonal Antibody-Drug ConjugateMEDIMMUNE LLC·Filed 2024·Application pending·0 cites
- 1375US2023201346A1Binding molecules specific for il-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1474US12312397B2Anti-O2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2022·Granted May 27, 2025·0 cites·15 claims
- 1573US12018068B2Anti-O1 antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Jun 25, 2024·0 cites·23 claims
- 1673US10022443B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2015·Granted Jul 17, 2018·1 cites·17 claims
- 1773US2025368723A1Anti-o2 antibodies and uses thereofMEDIMMUNE LLC·Filed 2025·Application pending·0 cites
- 1869US11912782B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2021·Granted Feb 27, 2024·0 cites·19 claims
- 1967US11529415B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2020·Granted Dec 20, 2022·0 cites·14 claims
- 2067US10588969B2Antibodies specific for IL-21 and uses thereofBOSTON PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 2151US2017073397A1MrkA Polypeptides, Antibodies, and Uses ThereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 2251US2009304683A1Soluble Fragments of The Sars-Cov Spike GlycoproteinDIMITROV DIMITER S·Filed 2007·Application pending·0 cites
- 2350US2019352425A1Assay to detect human dpp-4MEDIMMUNE LLC·Filed 2019·Application pending·0 cites
- 2449US2023331798A1Glycosylation-modified erythopoietin and use thereofJECHO LABORATORIES INC·Filed 2021·Application pending·0 cites
- 2547US2006240515A1Soluble fragments of the SARS-CoV spike glycoproteinDIMITROV DIMITER S·Filed 2006·Application pending·0 cites
- 2647US2019062411A1Mrka polypeptides, antibodies, and uses thereofMEDIMMUNE LLC·Filed 2018·Application pending·0 cites
- 2746US10351630B2Assay to detect human DPP-4MEDIMMUNE LLC·Filed 2016·Granted Jul 16, 2019·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Xiaodong Xiao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →